MIR3180-2 is a long non-coding RNA (lncRNA) that has been identified as highly co-expressed with Alzheimer's disease (AD)-related genes, suggesting a potential role in the disease's pathology [PMC7047416]. This lncRNA, along with MIR3180-3, is involved in targeting protein-coding genes (PCGs) associated with neuroprotective roles and blood vessel remodeling, which are critical processes in the context of AD [PMC7047416]. MIR3180-2 shares a significant number of co-expressed PCGs with MIR3180-3, including AD-related genes such as VTI1A and S100B [PMC7047416]. Furthermore, MIR3180-2 has been highlighted as a differentially expressed lncRNA in cerebral tissue and is considered a potential marker for AD alongside other lncRNAs like RP3-522J7 [PMC7047416]. Notably, it was found to be one of the top downregulated lncRNAs in an analysis focused on gene expression changes associated with AD [PMC7388310]. Co-expression network analysis underscores the importance of MIR3180-2 by showing its frequent co-expression with genes that increase the risk for AD [PMC8774680], indicating its potential utility in further research and therapeutic targeting for Alzheimer's disease.
ac a A C CGca g c gcg gggcgg gCUUCC GA GCUCCGCCCCACGU u cg ||| |||||| |||||| || |||||||||||||| | || c cgu cccgcc CGGAGG CU CGAGGCGGGGUgcg g gc -- C C U -aaa g c
Name | Accession | Chromosome | Start | End | Strand | Confidence |
---|
Disease | Description | Category | PubMed ID |
---|
Accession | MIMAT0015057 |
Description | Homo sapiens hsa-miR-3180-5p mature miRNA |
Sequence | 14 - CUUCCAGACGCUCCGCCCCACGUCG - 38 |
Evidence |
experimental
Illumina [1] |
Database links |
![]() ![]() ![]() |
Predicted targets |
![]() ![]() ![]() |
Accession | MIMAT0015058 |
Description | Homo sapiens hsa-miR-3180-3p mature miRNA |
Sequence | 58 - UGGGGCGGAGCUUCCGGAGGCC - 79 |
Evidence |
experimental
Illumina [1] |
Database links |
![]() ![]() ![]() |
Predicted targets |
![]() ![]() ![]() |
|